8-K: CNO Financial Group Reports Strong Fourth Quarter and Full Year 2023 Results

CNO Financial Group announced strong fourth quarter earnings and sustained full-year sales momentum, driven by agent force growth and strategic initiatives.

Summary

• CNO Financial Group reported a net income of $36.3 million, or $0.32 per diluted share, for the fourth quarter of 2023, compared to $38.0 million, or $0.33 per diluted share, in the same period of 2022.
• The company's full-year 2023 net income was $276.5 million, or $2.40 per diluted share, a decrease from $630.6 million, or $5.36 per diluted share, in 2022, with both years impacted by non-economic market factors.
• Net operating income for the fourth quarter of 2023 was $133.9 million, or $1.18 per diluted share, a significant increase from $82.9 million, or $0.71 per diluted share, in the fourth quarter of 2022.
• For the full year 2023, net operating income was $356.1 million, or $3.09 per diluted share, slightly down from $360.4 million, or $3.06 per diluted share, in 2022.
• Significant items positively impacted both net income and net operating income by $26.4 million, or $0.23 per diluted share, in the fourth quarter of 2023, and by $43.3 million, or $0.37 per diluted share, for the full year.
• Total new annualized premiums (NAP) increased by 9% for the full year 2023, with health insurance NAP up 11% and consumer division field NAP up 16%.
• The company returned $233.2 million to shareholders during 2023.
• Return on equity (ROE) was 14.0%, and operating ROE, as adjusted, was 9.8% for the full year 2023.
• The company's book value per share was $20.26, and book value per diluted share, excluding accumulated other comprehensive loss, was $33.94.
• CNO adopted a new accounting standard, ASU 2018-12, effective January 1, 2023, which resulted in a $368.0 million increase to shareholders' equity as of December 31, 2022.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong earnings growth, sales momentum, and strategic initiatives. The company's focus on capital management and shareholder returns further enhances the positive outlook.

Positives

• CNO delivered strong earnings growth in the fourth quarter and exceptional full-year operating performance.
• The company's diverse, integrated distribution generated four consecutive quarters of sales momentum.
• Agent counts increased, and there was record growth across multiple product categories.
• The company's capital position and free cash flow generation remained strong.
• A new Bermuda reinsurance structure enhanced the company's capital position.
• The company delivered solid earnings results in the year, driven by stable insurance product margins and improved investment portfolio yield.
• CNO returned more than $230 million to shareholders during 2023.
• The company enters 2024 with considerable sales momentum and a growing agent force amid favorable macro trends.
• The company continues to prioritize strong capital management and profitable growth.

Negatives

• Net income for the year ended December 31, 2023, was lower than the previous year, primarily due to non-economic market impacts.
• Investment income not allocated to product lines decreased by 15% for the year.
• Operating return, excluding significant items, on equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards for the year ended December 31, 2023, was 8.6%, down from 10.3% in 2022.
• The company experienced a decrease in net income and net operating income in the fourth quarter of 2022 due to the adoption of a new accounting standard.

Risks

• The company's financial results are subject to non-economic market impacts, which can cause fluctuations in earnings.
• Changes in market interest rates and equity impacts can affect the estimated fair values of embedded derivatives and market risk benefits.
• The company's performance is subject to changes in actuarial assumptions, which can impact insurance margins.
• The company's investment portfolio is subject to credit risk and market risk.
• The company's statutory risk-based capital ratio is subject to market volatility.

Future Outlook

CNO enters 2024 with considerable sales momentum and a growing agent force amid favorable macro trends, prioritizing strong capital management and profitable growth to deliver enduring value to its stakeholders.

Management Comments

• CNO delivered strong earnings growth in the quarter and exceptional full-year operating performance, said Gary C. Bhojwani, chief executive officer.
• Our diverse, integrated distribution generated four consecutive quarters of sales momentum, increased agent counts and record growth across multiple product categories.
• This high level of operating performance underscores the health and strength of our business model and will contribute to sustained profitable growth.
• Our capital position and free cash flow generation remained strong, enhanced by our new Bermuda reinsurance structure.
• We delivered solid earnings results in the year, driven by stable insurance product margins and improved investment portfolio yield.
• During 2023, we returned more than $230 million to shareholders.
• We continue to prioritize strong capital management and profitable growth, which are the cornerstone of our commitment to deliver enduring value to our customers, associates, agents and shareholders.

Industry Context

This announcement reflects a positive trend in the insurance sector, with CNO demonstrating strong sales growth and effective capital management, which are key indicators of a healthy and competitive insurance company.

Comparison to Industry Standards

• CNO's 9% growth in total new annualized premiums (NAP) for 2023 is a strong result, indicating a competitive position in the insurance market, especially when compared to industry averages which often see single-digit growth.
• The company's operating ROE of 9.8% is a solid performance, though it is important to compare this to peers like Prudential Financial or MetLife, which may have different risk profiles and capital structures.
• The establishment of CNO Bermuda Re is a strategic move to enhance capital efficiency, similar to what other large insurers like AIG or Reinsurance Group of America have done to optimize their capital structures.
• CNO's focus on the middle market and its diverse distribution model are key differentiators, setting it apart from companies that focus on high-net-worth individuals or rely solely on direct sales.
• The company's book value per diluted share, excluding accumulated other comprehensive loss, at $33.94, is a key metric for investors, and it is important to compare this to the book value of similar companies to assess relative valuation.

Stakeholder Impact

• Shareholders will benefit from the company's strong financial performance and capital returns.
• Employees and agents will benefit from the company's growth and strategic initiatives.
• Customers will benefit from the company's diverse product offerings and commitment to value.
• Creditors will benefit from the company's strong capital position and liquidity.

Next Steps

• The company will host a conference call on February 7, 2024, to discuss the results.
• CNO will continue to prioritize strong capital management and profitable growth in 2024.
• The company will focus on sustaining sales momentum and growing its agent force.

Key Dates

Keywords

financial results, net income, net operating income, new annualized premiums, agent growth, reinsurance, return on equity, insurance, annuities, health insurance, life insurance, capital management, shareholder returns